Ipsen and Skyhawk announce $1.8bn partnership to advance rare neurological disease therapies
The agreement gives Ipsen an option to receive exclusive global rights to two candidates
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Ipsen and Skyhawk announce $1.8bn partnership to advance rare neurological disease therapies
The agreement gives Ipsen an option to receive exclusive global rights to two candidates
Takeda gains rights to Kumquat’s immune-oncology programme in deal worth over $1.2bn
The selected candidate can be developed as a monotherapy, combination therapy or both
NICE recommends Menarini’s Nexpovio combination to treat multiple myeloma
More than 4,500 new patients are diagnosed with this form of blood cancer every year in the UK
Sanofi announces UK launch of inactivated rabies vaccine Verorab for all age groups
The rare neurotrophic virus is responsible for an estimated 59,000 global deaths every year
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Latest content
Havas Life Medicom and Sciterion appoint Dick Dunford as group creative director
Dunford recently served as executive creative director at TBWA\WorldHealth
Read More
minds + assembly appoints Nick Colucci to board of directors
Colucci previously served as chief executive officer and chairman of Publicis Health
Read More
dna Communications appoints Niamh Mangan as executive vice president and managing director
Mangan joins from 90TEN, where she most recently served as managing director
Read More
Intelligence
Behavioural science – the route to healthcare salvation?
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read More
Women’s health – managing the menopause
PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new treatments for menopause symptoms, the unmet need and the company’s commitment to midlife women’s health
Read More
The killer question
Expert strategists ask four crucial questions – the first one confounds most of us
Read More
The battle against counterfeit drugs
PME spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
Read More
The threat of AMR – when the drugs no longer work…
In the face of the increasing threat from AMR, the recent Bioinfect 2024 conference offers five reasons to be hopeful
Read More
Enhancing collaborative decision-making for patients with MS
Optimising MS care and patient outcomes through advancing shared decision-making
Read More
Blogs
Latest
Research conducted for Johnson and Johnson published in scientific journal
April 17, 2024 | Research Partnership|
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
Why choose a B Corp agency?
April 16, 2024 | Wallace Health|B Corp, ethical marketing, social and environmental impact
Going through the B Corp process – and successfully gaining certification at the end of last year – gave us a stronger sense of our …
Getting Past the Old-Fashioned View of Patient Advocacy
April 16, 2024 | Medscape Education Global|Leadership, Women in healthcare, healthcare
Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is …
Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance
April 15, 2024 | Research Partnership|Brand Strategy, Connected Solutions, Customer Engagement, market research
The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were …
Mile High Impact at AAN 2024
April 11, 2024 | Medscape Education Global|
The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this …
Navigating the future of AI: Insights from EphMRA’s one day meeting in London
April 22, 2024 | Research Partnership|
Authored by: Ellie Forde and Mark Braund, Directors
Navigating Stress: Understanding, Addressing, and Supporting Our Team
April 17, 2024 | Mednet Group|Stress Awareness Month
Explore how we’re supporting our team with managing stress in the workplace
Autoimmune conditions: Living With syndicated patient reports
April 11, 2024 | Research Partnership|
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective …
What role does ICER play in US market access?
April 9, 2024 | Mtech Access|
The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come …
Autism Acceptance Week 2024
April 4, 2024 | Mednet Group|Diversity and Inclusion, neurodiversity, thought leadership
Find out more about autism and how we’re supporting autistic people in the workplace
Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4
April 18, 2024 | Impetus Digital | Asynchronous touchpoints, DOL engagement, HCP engagement, KOL Engagement, MSL engagement, Pharma engagement, Virtual Pharma, Virtual advisory board, digital advisory board, pharma innovation, pharma virtual meeting